Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
Sarana Meditama Metropolitan Tbk
SAME
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
1
ROE
0,31%
ROA
0,21%
Book Value
223
Net Income
6,02 M
Total Sales
989,88 M
Total Assets
5,71 T
DER
0.40x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
9,53%
ELANG MAHKOTA TEKNOLOGI TBK, PT 🔗
84,83%
Corporate · Lokal
PT PAKUWON JATI 🔗
4,12%
Corporate · Lokal
PT TRIMEGAH SEKURITAS INDONESIA TBK 🔗
1,52%
Securities Company · Lokal
Tentang Perusahaan
PT Sarana Meditama Metropolitan (the Company) was established based on Notarial Deed No. 27 of Budiarti Karnadi, S.H., dated November 13, 1984
Produk & Lini Bisnis
The Company scope of business is healthcare service by building and operating hospitals. Currently, the Company's nusiness activity is the hospital management of OMNI Pulomas located in Pulomas, East Jakarta and OMNI Alam Sutera located in Serpong, South Tangerang which is owned and managed by Subsidiary.
Dewan Direksi
JH
Jusup Halimi
President Director
JG
Juniwati Gunawan
Vice President Director
MD
Meta Dewi Thedja
Director
DN
drg. Nailufar, MARS
Director
K
Kusmiati
Director
AA
Armen Antonius Djan
Director
Dewan Komisaris
RP
Robert Pakpahan
President Commissioner/Ind.
UC
Unggung Cahyono
Independent Commissioner
HK
Heru Kristiyana
Independent Commissioner
AT
Alexander Tedja
Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT Sarana Meditama International
Healthcare
 Tangerang 99.99%
PT Kurnia Sejahtera Utama
Healthcare
 Bekasi 99.99%
PT Sarana Meditama Anugerah
Healthcare
 Cikarang 99.99%
PT Sarana Meditama Nusantara
Healthcare
 Tangerang 99.99%
PT Sentosa Indah Sejahtera
Healthcare
 Tangerang 99.99%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
1,9M 1,4M 931jt 465jt 0 Sales 2025Q2: Rp 875.022.636 Net Income 2025Q2: Rp 14.294.332 2025Q2 Sales 2025Q3: Rp 1.367.289.936 Net Income 2025Q3: Rp 32.902.035 2025Q3 Sales 2025Q4: Rp 1.861.971.853 Net Income 2025Q4: Rp 30.075.777 2025Q4 Sales 2026Q1: Rp 479.093.567 Net Income 2026Q1: Rp -838.672 2026Q1 Sales 2026Q2: Rp 989.879.600 Net Income 2026Q2: Rp 6.024.894 2026Q2
2025 Q2
EPS 2
ROE 0,75%
2025 Q3
EPS 3
ROE 1,15%
2025 Q4
EPS 2
ROE 0,79%
2026 Q1
EPS -0
ROE -0,09%
2026 Q2
EPS 1
ROE 0,31%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 989,88 M 6,02 M 5,71 T 3,83 T 1 0,31% 0.40x
2026 Q1 479,09 M -838,67 Jt 5,77 T 3,82 T -0 -0,09% 0.41x
2025 Q4 1,86 T 30,08 M 5,80 T 3,80 T 2 0,79% 0.43x
2025 Q3 1,37 T 32,90 M 5,78 T 3,82 T 3 1,15% 0.42x
2025 Q2 875,02 M 14,29 M 5,59 T 3,80 T 2 0,75% 0.38x
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 354 223 0,21%
2026 1 342 223 -0,06%
2025 4 362 222 0,52%
2025 3 312 223 0,76%
2025 2 250 221 0,51%
Data diperbarui pada: 2026-05-12 11:50:18